Skip to NavigationSkip to content

News

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030.
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid patent challenges through a...
The National Institutes of Health (NIH) has unveiled that it is injecting funding into ACT NOW, a study to evaluate treatment options for newborns...
Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to deliver smallpox vaccines...
In the midst of ongoing discussions over drug pricing, the FDA has unveiled plans to facilitate accelerated access to generic versions of complex...
Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of the flu virus.
The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a three-year Brexit transition...
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could be effective against most...
Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant treatment for HER2-...
CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two years ago, paying $20 million to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches